EFHHBBBMS · Endothelial Hedgehog autocrine signaling at the Blood Brain Barrier controls inflammatory Central Nervous System lesion size and severity through Gas1 co-receptor modulation.
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2019-01-15 → 2021-01-14
- EU contribution
- €173,076
- Participants
- 1
- Scheme
- MSCA-IF-EF-ST
Lines connect the coordinator with its partners.
Results in brief
Endothelial Hedgehog autocrine signaling at the Blood Brain Barrier controls inflammatory CentralNervous System lesion size and severity through Gas1 co-receptor modulation.
In a healthy individual, the central nervous system (CNS) parenchyma is protected from the peripheral circulation by the blood–brain barrier (BBB). Importantly, during multiple sclerosis, the abnormal permeability of the BBB allows penetration into the CNS of inflammatory cells and plasmatic proteins which drive lesion formation. Previous studies have identified the Hedgehog (HH) pathway as a regulator of BBB integrity in multiple sclerosis, HIV, and stroke and we showed that desert hedgehog (DHH) is expressed constitutively at the BBB in adults. Interestingly, a wealth of literature has enabled a change in the vision of BBB structure and integrity, which has expanded to include contributions from both barrier properties of the vascular endothelial cells and the astrocytic end feet of the neurovascular unit. While it is now well established that BBB breakdown leads to soluble factor and inflammatory cell infiltration into the CNS during neuropathology, the role of the Glia Limitans is more complex. Indeed, astrocytes, described as reactive, may demonstrate opposing roles in both recruiting and restricting neuroinflammatory infiltration depending on the context. Specifically, in multiple sclerosis, it has been shown that reactive astrocytes, on one hand, produce pro-inflammatory and pro-permeability factors and on the other hand, neuroprotective factors. Astrocyte barrier properties are not as well characterized as those of the BBB. However, several groups have highlighted barrier properties at the Glia Limitans which is also required for immune cell trafficking across the neurovascular unit. Strikingly, our recent work has given considerable attention to a new property of reactive astrocytes: the expression of tight junction proteins, notably Claudin4, under inflammatory conditions. This result provides yet another argument in favor of astrocytic barrier properties.The first objective of our study was to decipher the role of Dhh in maintaining BBB tightness. The second objective was to demonstrate that a double barrier system comprising both the BBB and Glia Limitans is implemented in the CNS and regulated by a crosstalk going from endothelial cell to astrocytes using endothelial Dhh knockdown as a model of permeable BBB.
Data: CORDIS, © European Union
Project objective
Being at a major turning point in my career, after a rewarding postdoctoral fellowship in the United States, I’m applying to the MSCA-IF-2017 to ensure my return to Europe as an independent researcher in neurovascular biology. I built a proposal with the purpose of providing new understanding of Blood Brain Barrier (BBB) pathophysiology, particularly in the setting of Multiple Sclerosis. My hypothesis is that Desert Hedgehog-induced autocrine signaling in endothelial cells controls inflammatory lesion expansion via the regulation of intercellular junctions at the BBB through its co-receptor Gas1, and that this pathway may represent a new target for more effective therapies to prevent relapses and progression in Multiple Sclerosis.I choose to join the UMR Inserm U1034 to bring together my deep BBB knowledge and its unique expertise in Hedgehog signaling and vascular biology. Moreover the Bordeaux University, through its internationally recognized neuroscience campus, offers me an exceptional opportunity to develop fruitful collaborations with many distinguished researchers.My project is voluntarily built towards the exploitation of novel dynamic in vitro/in vivo BBB models requiring original microfluidic chamber design and 2-Photon live imaging (secondment in M. Nedergaard’s laboratory, Copenhagen), in vivo explorations of yet unpublished transgenic mice using high resolution imaging tools and the development of new molecules targeting original protein-protein interactions.As soon as I'll get exciting data, I will disseminate my work through seminars, international conferences and publications in high impact factor journals. Moreover, I will use the opportunities from both my hosting structure and Neurocampus programs to communicate to a wider audience (laboratory visits, meetings, Brain awareness week contributor). Ultimately, this fellowship will establish my emerging status of ""young leader in neurovascular biology"" with an international collaborative network.""
Original text from CORDIS.
Participants
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE · ParisCoordinatorFrance
Links
Data: CORDIS, © European Union
